XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders’ Deficiency (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Jun. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
May 31, 2024
Mar. 22, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Accrued dividend payable $ 365,078           $ 365,078       $ 25,540
Common stock, stated value $ 0.001           $ 0.001       $ 0.001
Value of common stock issued for legal settlement     $ 45,000                
Common stock issued in satisfaction of convertible note payable interest   $ 4,680 $ 520                
Stock-based compensation expense $ 5,070     $ 25,962     $ 309,297 $ 404,978      
Unrecognized stock-based compensation expense $ 0           0        
Convertible Notes Payable [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants to purchase common stock                   4,321,926  
Exercise price                   $ 1.25  
Investor [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants term                 10 years    
Warrants to purchase common stock                 625,000    
Exercise price                 $ 0.75    
Fair value of warrants                 $ 96,710    
Series A, B and C Convertible Preferred Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Number of common stock issued   904,049                  
Common stock, stated value   $ 0.75       $ 0.75          
Aggregate value convertible preferred stock   $ 677,982                  
Series B Convertible Preferred Stock [Member] | Investor [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Proceeds from issuance of convertible preferred stock             $ 776,001        
Common stock, shares             103,464        
Warrants term 5 years           5 years        
Warrants to purchase common stock 1,164,000           1,164,000        
Exercise price $ 0.75           $ 0.75        
Fair value of warrants $ 166,500           $ 166,500        
Series C Convertible Preferred Stock [Member] | Convertible Notes Payable [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Shares issued upon debt conversion     13,333                
Fair value     $ 1,700                
Preferred Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Additional accrued dividend payable 350,984     309,150     1,017,520 907,516      
Accrued dividend payable $ 365,078           365,078       $ 25,540
Preferred Stock [Member] | Series B Convertible Preferred Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Common stock, shares 3,333 96,798 3,333                
Value of common stock issued for legal settlement                    
Common stock issued in satisfaction of convertible note payable interest                  
Preferred Stock [Member] | Series C Convertible Preferred Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Value of common stock issued for legal settlement                    
Common stock issued in satisfaction of convertible note payable interest                  
Common Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Number of common stock issued   904,049     802,880            
Number of common stock issued for legal settlement     180,000                
Value of common stock issued for legal settlement     $ 180                
Common stock issued in satisfaction of convertible note payable interest, shares   18,000 2,000                
Common stock issued in satisfaction of convertible note payable interest   $ 18 $ 2                
Common Stock [Member] | Consulting Services [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock-based compensation expense       1,832     272,493 341,269      
Stock-based compensation expense included in accrued compensation             7,293 11,269      
Stock-based compensation expense included in stockholder's deficiency             265,200 330,000      
Common Stock [Member] | Convertible Notes Payable [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Common stock issued in satisfaction of convertible note payable interest, shares   18,000       2,000          
Common stock issued in satisfaction of convertible note payable interest           $ 5,200          
Common Stock [Member] | Convertible Notes Payable [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Shares issued upon debt conversion     6,546                
Fair value $ 3,000           $ 3,000        
Common Stock [Member] | Investor [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Proceeds from issuance of convertible preferred stock $ 415,625                    
Common stock, shares 1,312,500                    
Warrants term 5 years           5 years        
Warrants to purchase common stock 1,312,500           1,312,500        
Exercise price $ 0.35           $ 0.35        
Fair value of warrants $ 287,455           $ 287,455        
Common Stock [Member] | Consultants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock issued for service     1,000,000                
Stock issued for service, value     $ 260,000                
Warrant [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock-based compensation expense 1,408     24,130     36,804 63,709      
Stock-based compensation expense included in accrued compensation $ 3,662     372     (1,175) (649)      
Stock-based compensation expense included in stockholder's deficiency       $ 23,758     $ 37,979 $ 64,358      
Warrant [Member] | Advisory Agreement [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants term     5 years                
Warrants to purchase common stock     100,000                
Exercise price     $ 1.25                
Fair value of warrants     $ 6,590                
Warrant vesting percentage     20.00%